Global Cannula Market Size, Share, Forecast Report, 2024-2033
The global cannula market size was exhibited at USD 167.90 million in 2023 and is projected to hit around USD 346.05 million by 2033, growing at a CAGR of 7.5% during the forecast period of 2024 to 2033.
Key Takeaways:
Cannula Market Report Scope
| Report Coverage | Details |
| Market Size in 2024 | USD 167.90 Million |
| Market Size by 2033 | USD 346.05 Million |
| Growth Rate From 2024 to 2033 | CAGR of 7.5% |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Segments Covered | Product, Type, Material, Size, End-use, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
| Key Companies Profiled | Medtronic; Becton Dickinson (BD); Edward Lifesciences; LivaNova; Smiths Medical; Boston Scientific Corporation |
The increase in demand for minimally invasive surgeries, the rise in the number of surgeries among the geriatric population, and the significant increase in the prevalence of chronic lifestyle-related diseases such as diabetes and cardiovascular diseases are the primary factors that are driving the growth of the cannula market. In addition, factors such as government initiatives to provide primary healthcare services at affordable rates and increase awareness regarding chronic diseases are also anticipated to further help the market grow significantly during the forecast period. The cannula market experienced a mixed impact during the pandemic.
While there was a significant surge in demand for nasal cannula for the treatment of COVID-19 patients, the dermatology segment experienced a temporary drop in sales due to the restriction of elective surgeries. However, the dermatology segment recovered during the second half of the pandemic.
With a large population being infected with the COVID-19 virus, it can be projected that there could be a rise in respiratory diseases in the future since the virus poses a great threat to the respiratory system. Moreover, with the opening of economies and the world moving towards normalcy, the market is projected to experience lucrative growth during the forecast per
Minimally invasive surgeries are gaining popularity in the healthcare industry. There has been a rapid increase in the preference for minimally invasive surgeries for the treatment of cardiovascular diseases. This is since minimally invasive surgeries cause less surgical trauma and result in a better aesthetic appearance. It offers advantages such as smaller incisions, minimized infection risks, smaller scars, a lesser amount of bleeding, and lesser pain & trauma. Thus, this is leading to an increased preference for minimally invasive surgeries which in turn is expected to boost the growth of the cannula market.
Segments Insights:
Product Insights
Based on product, the cannula market is segmented into cardiac (arterial, venous, cardioplegia and others) dermatology, nasal and others. The cardiac segment held the largest market with 46.3% share in 2023. This is attributed to the high prevalence of cardiovascular diseases. Increasing shift towards sedentary lifestyle, consumption of processed foods and reduced amounts of physical activities is leading to a rise in prevalence of cardiovascular disease. In addition, the increase in geriatric population that is higher risk of developing these diseases is also contributing to a significant rise in cardiovascular diseases. Thus, the rise in the prevalence of cardiovascular diseases is a major factor responsible for the dominance of cardiac segment in the cannula market.
The dermatology segment is expected to administer significant growth over the forecast period. This is due to the increasing use of microcannula to avoid complications during and after procedures. Moreover, there is a significant rise in the number of cosmetic surgeries being carried out which is anticipated to further boost the demand for dermatology segment. According to a research paper published in 2021, every year providers carry out more than 15 million cosmetic surgery procedures in the U.S. Thus, increase in penetration MIS is expected to gain segment growth over the forecast period.
Type Insights
Based on type, the market is fragmented into neonatal, straight, winged, a wing with port, and winged with stop cork cannulae. The straight cannulae segment dominated the market with the highest market share in 2023 and is anticipated to grow at a CAGR of 7.5% over the forecast period. This is due to its design which makes it simpler to use. The product’s extra sharp needle makes it easier to insert as well. Therefore, these types of cannulae are used in cardiac surgeries to avoid any mishaps and cut down any unnecessary delay that may lead to stretching the entire process.
On the other hand, neonatal cannulae are expected to register maximum growth with the highest CAGR during the forecast period. The primary factor contributing to the growth of this segment is the increase in the prevalence of respiratory problems among neonates. The soft and flexible nature of neonatal cannulae makes them highly suitable for use in high flow oxygen therapy for newborns. According to a research paper published by the National Library of Medicine, in 2016, 33.3% of all neonatal admissions at >28 weeks’ gestation, excluding infants with syndromes and those with congenital or surgical conditions, had respiratory conditions as their primary reason for admission.
Material Insights
Based on material, the market is segmented into plastic, metal, and silicone. The plastic segment held the highest market share with 60.0% in 2023 due to its increased adoption rate in both in-patient and out-patient procedures. Most plastic cannulas are translucent and allow surgeons to visualize instrumentation & sutures passing through the cannula in shoulder arthroscopy. Thus, making it suitable for using it in maximum procedures which are leading to its dominance throughout the forecast period.
However, the silicone segment is anticipated to experience maximum growth during the forecast period. This is attributed to the increasing usage of silicone cannulas in oxygen therapies, to ensure the continuous supply of oxygen to patients during surgery and for people suffering from respiratory disorders. Moreover, silicone cannulas are soft and flexible which makes them a preferred choice for application among healthcare professionals and patients.
Size Insights
Based on size, the market is segmented into 14G,16G,18G, 20G, 22G, 24G, and 26G. Different sized cannulas are represented by different colors. The 18G size accounted for the highest market share in 2023 and this trend is expected to continue throughout the forecast period. This is because the 18G size cannula is most widely used in hospitals for adults as well as adolescents. 18G cannulas are used to infuse blood products and deliver medications. These cannulas aim for quick blood transfusion. Moreover, these are also used for computed tomography/pulmonary embolism protocols or other testing that needs large IV sizes.
The 22G size cannulas are expected to experience the highest growth of 7.8% CAGR during the forecast period. This can be attributed to its small gauge size which allows a faster flow of fluid in patients with complicated veins. According to a research study published in the Journal of Vascular Access in 2018, the majority of patients are treated successfully with one long peripheral cannula for the duration of their treatment without the need for further cannulation.
End-use Insights
Based on end-use, the market is classified into hospitals, ambulatory surgical centers, and others. The others segment includes blood banks, research centers, and pathology labs. The hospitals segment held the maximum market share in 2023 with 53.2%. This is due to the rise in hospitalization rate for a variety of causes and treatments. Cannulas are used in a wide variety of specialty departments in the hospitals including orthopedic surgery, cardiovascular surgery, neurology, gynecology, general surgery, oxygen therapy, dermatology, and many more.
Ambulatory surgical centers are projected to witness the fastest growth throughout the forecast period. Ambulatory surgical centers are modern healthcare facilities that offer same-day surgical care, along with preventive and diagnosis procedures. Thus, there is a rise in the shift towards ambulatory surgical centers to undergo treatment and avoid hospitalization. This in turn is leading to a rise in the number of ambulatory surgical centers. Currently, there are more than 9,280 active ambulatory surgical centers in the U.S.
Regional Insights
North America dominated the market with the highest revenue share of 41.0% in 2023 and is expected to witness a CAGR of 7.8% over the forecast period. This is due to the availability of advanced healthcare facilities in the region and the presence of dominant market players. In addition, the increasing prevalence of lifestyle diseases in the region is also a major factor in its dominance. Other factors such as greater awareness about minimally invasive surgeries and the increasing adoption rate of cosmetic surgeries in this region are further driving the growth of the market in this region. According to the American Society of Plastic Surgeons, about 16.7 billion USD was spent on cosmetic procedures in 2020 in the U.S.
Asia Pacific is expected to experience lucrative growth during the forecast period owing to a drastic rise in the geriatric population in the region which creates a massive patient pool with individuals suffering from chronic diseases such as cardiovascular diseases and diabetes. Moreover, the increasing efforts by the government to introduce favorable policies to transform the healthcare sector, especially in the rural areas, is further expected to boost the growth of the market in this region.
Some of the prominent players in the cannula market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the global cannula market.
Product
Type
Material
Size
End-use
By Region
Chapter 1. Cannula Market: Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Type
1.1.3. Material
1.1.4. Size
1.1.5. End-use
1.1.6. Regional scope
1.1.7. Estimates and forecast timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Cannula Market: Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Cannula Market: Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.1.3. Reimbursement framework
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increase in demand for minimally invasive surgeries
3.2.1.2. Rise in the number of surgeries in geriatric population
3.2.1.3. Increase in prevalence of lifestyle-related diseases
3.2.2. Market restraint analysis
3.2.2.1. Stringent Regulations
3.2.2.2. Lack of Skilled Professionals
3.3. Cannula Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Major Deals & Strategic Alliances Analysis
3.3.4. Market Entry Strategies
Chapter 4. Cannula Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2024 & 2033
4.2. Segment Dashboard
4.3. Global Cannula Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.4.1. Cardiac
4.4.1.1. Market estimates and forecast 2021 to 2033
4.4.2. Dermatology
4.4.2.1. Market estimates and forecast 2021 to 2033
4.4.3. Nasal
4.4.3.1. Market estimates and forecast 2021 to 2033
4.4.4. Others
4.4.4.1. Market estimates and forecast 2021 to 2033
Chapter 5. Cannula Market: Type Estimates & Trend Analysis
5.1. Type Market Share, 2024 & 2033
5.2. Segment Dashboard
5.3. Global Cannula Market by Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.4.1. Neonatal cannulae
5.4.1.1. Market estimates and forecast 2021 to 2033
5.4.2. Straight cannulae
5.4.2.1. Market estimates and forecast 2021 to 2033
5.4.3. Winged cannulae
5.4.3.1. Market estimates and forecast 2021 to 2033
5.4.4. Wing with port
5.4.4.1. Market estimates and forecast 2021 to 2033
5.4.5. Winged with stop cork
5.4.5.1. Market estimates and forecast 2021 to 2033
Chapter 6. Cannula Market: Material Estimates & Trend Analysis
6.1. Material Market Share, 2024 & 2033
6.2. Segment Dashboard
6.3. Global Cannula Market by Material Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.4.1. Plastic
6.4.1.1. Market estimates and forecast 2021 to 2033
6.4.2. Metal
6.4.2.1. Market estimates and forecast 2021 to 2033
6.4.3. Silicone
6.4.3.1. Market estimates and forecast 2021 to 2033
Chapter 7. Cannula Market: Size Estimates & Trend Analysis
7.1. Size Market Share, 2024 & 2033
7.2. Segment Dashboard
7.3. Global Cannula Market by Size Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
7.4.1. 14G
7.4.1.1. Market estimates and forecast 2021 to 2033
7.4.2. 16G
7.4.2.1. Market estimates and forecast 2021 to 2033
7.4.3. 18G
7.4.3.1. Market estimates and forecast 2021 to 2033
7.4.4. 20G
7.4.4.1. Market estimates and forecast 2021 to 2033
7.4.5. 22G
7.4.5.1. Market estimates and forecast 2021 to 2033
7.4.6. 24G
7.4.6.1. Market estimates and forecast 2021 to 2033
7.4.7. 26G
7.4.7.1. Market estimates and forecast 2021 to 2033
Chapter 8. Cannula Market: End-use Estimates & Trend Analysis
8.1. End-use Market Share, 2024 & 2033
8.2. Segment Dashboard
8.3. Global Cannula End-use by Material Outlook
8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
8.4.1. Hospital
8.4.1.1. Market estimates and forecast 2021 to 2033
8.4.2. Ambulatory Surgical Centers
8.4.2.1. Market estimates and forecast 2021 to 2033
8.4.3. Others
8.4.3.1. Market estimates and forecast 2021 to 2033
Chapter 9. Cannula Market: Regional Estimates & Trend Analysis
9.1. Regional market share analysis, 2024 & 2033
9.2. Regional Marketplace: Key Takeaways
9.3. North America
9.3.1. SWOT Analysis
9.3.2. Market estimates and forecast, 2021 - 2033
9.3.3. U.S.
9.3.3.1. Country Dynamics
9.3.3.2. Country Variables
9.3.3.3. Competitive Landscape
9.3.3.4. Regulatory/Reimbursement Framework
9.3.3.5. Market estimates and forecast, 2021 - 2033
9.3.4. Canada
9.3.4.1. Country Dynamics
9.3.4.2. Country Variables
9.3.4.3. Competitive Landscape
9.3.4.4. Regulatory/Reimbursement Framework
9.3.4.5. Market estimates and forecast, 2021 - 2033
9.4. Europe
9.4.1. SWOT Analysis
9.4.2. Market estimates and forecast, 2021 - 2033
9.4.3. UK
9.4.3.1. Country Dynamics
9.4.3.2. Country Variables
9.4.3.3. Competitive Landscape
9.4.3.4. Regulatory/Reimbursement Framework
9.4.3.5. Market estimates and forecast, 2021 - 2033
9.4.4. Germany
9.4.4.1. Country Dynamics
9.4.4.2. Country Variables
9.4.4.3. Competitive Landscape
9.4.4.4. Regulatory/Reimbursement Framework
9.4.4.5. Market estimates and forecast, 2021 - 2033
9.4.5. France
9.4.5.1. Country Dynamics
9.4.5.2. Country Variables
9.4.5.3. Competitive Landscape
9.4.5.4. Regulatory/Reimbursement Framework
9.4.5.5. Market estimates and forecast, 2021 - 2033
9.4.6. Italy
9.4.6.1. Country Dynamics
9.4.6.2. Country Variables
9.4.6.3. Competitive Landscape
9.4.6.4. Regulatory/Reimbursement Framework
9.4.6.5. Market estimates and forecast, 2021 - 2033
9.4.7. Spain
9.4.7.1. Country Dynamics
9.4.7.2. Country Variables
9.4.7.3. Competitive Landscape
9.4.7.4. Regulatory/Reimbursement Framework
9.4.7.5. Market estimates and forecast, 2021 - 2033
9.4.8. Denmark
9.4.8.1. Country Dynamics
9.4.8.2. Country Variables
9.4.8.3. Competitive Landscape
9.4.8.4. Regulatory/Reimbursement Framework
9.4.8.5. Market estimates and forecast, 2021 - 2033
9.4.9. Sweden
9.4.9.1. Country Dynamics
9.4.9.2. Country Variables
9.4.9.3. Competitive Landscape
9.4.9.4. Regulatory/Reimbursement Framework
9.4.9.5. Market estimates and forecast, 2021 - 2033
9.4.10. Norway
9.4.10.1. Country Dynamics
9.4.10.2. Country Variables
9.4.10.3. Competitive Landscape
9.4.10.4. Regulatory/Reimbursement Framework
9.4.10.5. Market estimates and forecast, 2021 - 2033
9.5. Asia Pacific
9.5.1. SWOT Analysis
9.5.2. Market estimates and forecast, 2021 - 2033
9.5.3. Japan
9.5.3.1. Country Dynamics
9.5.3.2. Country Variables
9.5.3.3. Competitive Landscape
9.5.3.4. Regulatory/Reimbursement Framework
9.5.3.5. Market estimates and forecast, 2021 - 2033
9.5.4. China
9.5.4.1. Country Dynamics
9.5.4.2. Country Variables
9.5.4.3. Competitive Landscape
9.5.4.4. Regulatory/Reimbursement Framework
9.5.4.5. Market estimates and forecast, 2021 - 2033
9.5.5. India
9.5.5.1. Country Dynamics
9.5.5.2. Country Variables
9.5.5.3. Competitive Landscape
9.5.5.4. Regulatory/Reimbursement Framework
9.5.5.5. Market estimates and forecast, 2021 - 2033
9.5.6. Australia
9.5.6.1. Country Dynamics
9.5.6.2. Country Variables
9.5.6.3. Competitive Landscape
9.5.6.4. Regulatory/Reimbursement Framework
9.5.6.5. Market estimates and forecast, 2021 - 2033
9.5.7. Thailand
9.5.7.1. Country Dynamics
9.5.7.2. Country Variables
9.5.7.3. Competitive Landscape
9.5.7.4. Regulatory/Reimbursement Framework
9.5.7.5. Market estimates and forecast, 2021 - 2033
9.5.8. South Korea
9.5.8.1. Country Dynamics
9.5.8.2. Country Variables
9.5.8.3. Competitive Landscape
9.5.8.4. Regulatory/Reimbursement Framework
9.5.8.5. Market estimates and forecast, 2021 - 2033
9.6. Latin America
9.6.1. SWOT Analysis
9.6.2. Market estimates and forecast, 2021 - 2033
9.6.3. Brazil
9.6.3.1. Country Dynamics
9.6.3.2. Country Variables
9.6.3.3. Competitive Landscape
9.6.3.4. Regulatory/Reimbursement Framework
9.6.3.5. Market estimates and forecast, 2021 - 2033
9.6.4. Mexico
9.6.4.1. Country Dynamics
9.6.4.2. Country Variables
9.6.4.3. Competitive Landscape
9.6.4.4. Regulatory/Reimbursement Framework
9.6.4.5. Market estimates and forecast, 2021 - 2033
9.6.5. Argentina
9.6.5.1. Country Dynamics
9.6.5.2. Country Variables
9.6.5.3. Competitive Landscape
9.6.5.4. Regulatory/Reimbursement Framework
9.6.5.5. Market estimates and forecast, 2021 - 2033
9.7. MEA
9.7.1. SWOT Analysis
9.7.2. Market estimates and forecast, 2021 - 2033
9.7.3. South Africa
9.7.3.1. Country Dynamics
9.7.3.2. Country Variables
9.7.3.3. Competitive Landscape
9.7.3.4. Regulatory/Reimbursement Framework
9.7.3.5. Market estimates and forecast, 2021 - 2033
9.7.4. Saudi Arabia
9.7.4.1. Country Dynamics
9.7.4.2. Country Variables
9.7.4.3. Competitive Landscape
9.7.4.4. Regulatory/Reimbursement Framework
9.7.4.5. Market estimates and forecast, 2021 - 2033
9.7.5. UAE
9.7.5.1. Country Dynamics
9.7.5.2. Country Variables
9.7.5.3. Competitive Landscape
9.7.5.4. Regulatory/Reimbursement Framework
9.7.5.5. Market estimates and forecast, 2021 - 2033
9.7.6. Kuwait
9.7.6.1. Country Dynamics
9.7.6.2. Country Variables
9.7.6.3. Competitive Landscape
9.7.6.4. Regulatory/Reimbursement Framework
9.7.6.5. Market estimates and forecast, 2021 - 2033
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.2.1. Innovators
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.3.3. Key company market share analysis, 2024
10.3.4. Medtronic
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. Becton Dickinson (BD)
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Edward Lifesciences
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. LivaNova
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Smiths Medical
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. Boston Scientific Corporation
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers